Curtis C. Harris

Laboratory of Human Carcinogenesis
The Center for Cancer Research
United States of America

Scientist Genetics
Biography

Harris received his M.D. from Kansas University School of Medicine. He completed his clinical training in internal medicine at the University of California-Los Angeles, Washington Veterans Administrative Hospital and the NCI. He has held positions of increasing responsibility at the NCI, and is also a Clinical Professor of Medicine and Oncology at Georgetown University School of Medicine. Harris has received numerous honors throughout his distinguished career including the Alton Ochsner Award relating Smoking and Health (American College of Physicians), Deichmann Award (International Union of Toxicology), Charles Heidelberger Award (International Society of Gastroenterological Carcinogenesis) and the Distinguished Service Medal (the highest honor of the U.S. Public Health Service), NCI Outstanding Mentor Award in 2007 and 2013, Ph.D. (Honorary) Nippon University School of Medicine, the AACR-Princess Takamatsu Award and the AACR-American Cancer Society: Cancer Epidemiology and Prevention Award. Harris has published more than 500 journal articles, 142 book chapters, and 13 books, and holds more than 30 patents owned by the U.S. Government. He also serves as Editor-in-Chief for the journal, Carcinogenesis, and has held or currently holds elected offices in scholarly societies and non-profit foundations including the American Association of Cancer Research, the International Society of Differentiations, the Keystone Symposia on Molecular and Cellular Biology and Aspen Cancer Conference. Harris has a wide range of scientific interests and accomplishments spanning molecular genetics of human cancer to molecular epidemiology of human cancer risk. (Select links tab for Science Watch, CCR Connections Articles, two youtube videos. 

Research Intrest

Cancer Biology, Epidemiology, Genetics and Genomics, Health Disparities, Stem Cell Biology 

List of Publications
Ryan BM, Zanetti KA, Robles AI, Schetter AJ, Goodman J, et al. (2014) Germline variation in NCF4, an innate immunity gene, is associated with an increased risk of colorectal cancer. Int. J. Cancer. 134: 1399-1407.
Oue N, Anami K, Schetter AJ, Moehler M, Okayama H, et al. (2013) High miR-21 expression from FFPE tissues is associated with poor survival and response to adjuvant chemotherapy in colon cancer. Int. J. Cancer. 34: 1926-1934.
Akagi I, Okayama H, Schetter AJ, Robles AI, Kohno T, et al. (2013) Combination of protein coding and noncoding gene expression as a robust prognostic classifier in stage I lung adenocarcinoma. Cancer Res. 73: 3821-3832.
Mondal AM, Horikawa I, Pine SR, Fujita K, Morgan KM, et al. (2013) p53 isoforms regulate aging- and tumor-associated replicative senescence in T lymphocytes. J. Clin. Invest. 123: 5247-5257.
Mathe EA, Patterson AD, Haznadar M, Manna SK, Krausz KW, et al. (2014) Non-invasive urinary metabolomic profiling identifies diagnostic and prognostic markers in lung cancer. Cancer Res. 74: 3259-3270.